Jonah Jacob Scott-McKean
Affiliations: | 2012 | Neuroscience | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Google:
"Jonah Scott-McKean"Mean distance: 16.59 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Sukumar Vijayaraghavan | grad student | 2012 | University of Colorado, Denver | |
| (Pre-clinical assessment of memantine as a potential therapeutic agent for the treatment of Down syndrome.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Scott-McKean JJ, Jones R, Johnson MW, et al. (2023) Emergence of Treadmill Running Ability and Quantitative Assessment of Gait Dynamics in Young Ts65Dn Mice: A Mouse Model for Down Syndrome. Brain Sciences. 13 |
| Victorino DB, Pinheiro DJLL, Scott-McKean JJ, et al. (2021) Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome. Scientific Reports. 11: 9521 |
| Victorino DB, Scott-McKean JJ, Johnson MW, et al. (2020) Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down Syndrome. Investigative Ophthalmology & Visual Science. 61: 25 |
| Scott-McKean JJ, Roque AL, Surewicz K, et al. (2018) Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome. Neural Plasticity. 2018: 9235796 |
| M Lee Y, Zampieri BL, Scott-McKean JJ, et al. (2017) Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome. Stem Cells Translational Medicine |
| Costa AC, Scott-McKean JJ. (2013) Prospects for improving brain function in individuals with Down syndrome. Cns Drugs. 27: 679-702 |
| Scott-McKean JJ, Costa AC. (2011) Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 774-8 |
| Scott-McKean JJ, Chang B, Hurd RE, et al. (2010) The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials. Investigative Ophthalmology & Visual Science. 51: 3300-8 |
| Scott-McKean JJ, Wenger GR, Tecott LH, et al. (2008) 5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of Reinforcement. The Open Neuropsychopharmacology Journal. 1: 24-32 |
| Siddiqui A, Lacroix T, Stasko MR, et al. (2008) Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801. Genes, Brain, and Behavior. 7: 810-20 |